144 related articles for article (PubMed ID: 32802426)
1. WNT signaling pathway regulator-
Zhou Y; Li C; Peng J; Luo P; Xie C; Liu S; Chen G; Li T
J Thorac Dis; 2020 Jul; 12(7):3478-3487. PubMed ID: 32802426
[TBL] [Abstract][Full Text] [Related]
2. Investigation of Transcript Variant 6 of
Zhang X; O'Brien D; Zhang X
Oxid Med Cell Longev; 2022; 2022():7078787. PubMed ID: 36071863
[TBL] [Abstract][Full Text] [Related]
3. WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling.
Jiang S; Zhang M; Zhang Y; Zhou W; Zhu T; Ruan Q; Chen H; Fang J; Zhou F; Sun J; Yang X
Cell Commun Signal; 2019 Aug; 17(1):109. PubMed ID: 31462314
[TBL] [Abstract][Full Text] [Related]
4. SOX10 promotes the malignant biological behavior of basal-like breast cancer cells by regulating EMT process.
Yang K; Yun F; Shi L; Liu X; Jia YF
Heliyon; 2023 Dec; 9(12):e23162. PubMed ID: 38144326
[TBL] [Abstract][Full Text] [Related]
5. GEMIN4, a potential therapeutic targets for patients with basal-like subtype breast cancer.
Wu L; Zhang Y; Zheng C; Zhao F; Lin Y
BMC Womens Health; 2023 Jul; 23(1):396. PubMed ID: 37507701
[TBL] [Abstract][Full Text] [Related]
6. ANXA4 Activates JAK-STAT3 Signaling by Interacting with ANXA1 in Basal-Like Breast Cancer.
Li L; Zhang R; Liu Y; Zhang G
DNA Cell Biol; 2020 Sep; 39(9):1649-1656. PubMed ID: 32552056
[TBL] [Abstract][Full Text] [Related]
7. Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer.
Huang P; Liao R; Chen X; Wu X; Li X; Wang Y; Cao Q; Dong C
Theranostics; 2020; 10(10):4644-4658. PubMed ID: 32292520
[No Abstract] [Full Text] [Related]
8. FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.
Jin Y; Han B; Chen J; Wiedemeyer R; Orsulic S; Bose S; Zhang X; Karlan BY; Giuliano AE; Cui Y; Cui X
Ann Surg Oncol; 2014 Dec; 21 Suppl 4(0 4):S758-66. PubMed ID: 25124473
[TBL] [Abstract][Full Text] [Related]
9. Elevated transcription and glycosylation of B3GNT5 promotes breast cancer aggressiveness.
Miao Z; Cao Q; Liao R; Chen X; Li X; Bai L; Ma C; Deng X; Dai Z; Li J; Dong C
J Exp Clin Cancer Res; 2022 May; 41(1):169. PubMed ID: 35526049
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and characterization of FRAT2, encoding a positive regulator of the WNT signaling pathway.
Saitoh T; Moriwaki J; Koike J; Takagi A; Miwa T; Shiokawa K; Katoh M
Biochem Biophys Res Commun; 2001 Mar; 281(3):815-20. PubMed ID: 11237732
[TBL] [Abstract][Full Text] [Related]
11. The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression.
Shepherd JH; Uray IP; Mazumdar A; Tsimelzon A; Savage M; Hilsenbeck SG; Brown PH
Oncotarget; 2016 Mar; 7(11):13106-21. PubMed ID: 26894864
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory Effort of MLN2238 on Basal-Like Breast Cancer: An Investigation Based on the Gene Set Enrichment Analysis.
Wang D; Li Y; Luo F; Song X; Wu S; Chen Y; Zhang N
Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):143-149. PubMed ID: 37715393
[TBL] [Abstract][Full Text] [Related]
13. MFAP5 promotes basal-like breast cancer progression by activating the EMT program.
Wu Y; Wu P; Zhang Q; Chen W; Liu X; Zheng W
Cell Biosci; 2019; 9():24. PubMed ID: 30899449
[TBL] [Abstract][Full Text] [Related]
14. Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer.
She QB; Gruvberger-Saal SK; Maurer M; Chen Y; Jumppanen M; Su T; Dendy M; Lau YK; Memeo L; Horlings HM; van de Vijver MJ; Isola J; Hibshoosh H; Rosen N; Parsons R; Saal LH
BMC Cancer; 2016 Aug; 16():587. PubMed ID: 27484095
[TBL] [Abstract][Full Text] [Related]
15. Low expression of PinX1 is associated with malignant behavior in basal-like breast cancer.
Feng YZ; Zhang QY; Fu MT; Zhang ZF; Wei M; Zhou JY; Shi R
Oncol Rep; 2017 Jul; 38(1):109-119. PubMed ID: 28586040
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic activation of HORMAD1 in basal-like breast cancer: role in Rucaparib sensitivity.
Wang X; Tan Y; Cao X; Kim JA; Chen T; Hu Y; Wexler M; Wang X
Oncotarget; 2018 Jul; 9(53):30115-30127. PubMed ID: 30046392
[TBL] [Abstract][Full Text] [Related]
17. AGR2 and AGR3 play an important role in the clinical characterization and prognosis of basal like breast cancer.
de Moraes CL; Cruz E Melo N; Valoyes MAV; Naves do Amaral W
Clin Breast Cancer; 2022 Feb; 22(2):e242-e252. PubMed ID: 34462207
[TBL] [Abstract][Full Text] [Related]
18. Identification of key pathways and hub genes in basal-like breast cancer using bioinformatics analysis.
Yang K; Gao J; Luo M
Onco Targets Ther; 2019; 12():1319-1331. PubMed ID: 30863098
[TBL] [Abstract][Full Text] [Related]
19. [MicroRNA-205 targeted Krüppel-like factor 12 and regulated MDA-MB-468 cells apoptosis in basal-like breast carcinoma].
Guan B; Li Q; Li XH; Zhou XJ
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(26):2070-5. PubMed ID: 27468619
[TBL] [Abstract][Full Text] [Related]
20. Loss of ABAT-Mediated GABAergic System Promotes Basal-Like Breast Cancer Progression by Activating Ca
Chen X; Cao Q; Liao R; Wu X; Xun S; Huang J; Dong C
Theranostics; 2019; 9(1):34-47. PubMed ID: 30662552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
